Abstract: Problem to be Solved Provided is a packing box that enables to easily release a slit lock in which slits of an insertion piece of an openable lid engage with side flaps connected to openable lid side edge portions of lid side members, even if the interior of a box body of the packing box is tightly filled with a product.

Abstract: A packing box enables easy release a slit lock in which slits in an insertion piece of an openable lid engage side flaps connected to openable lid side edge portions of lid side members, even if the interior of a box body of the packing box is tightly filled with a product. The top face lid of the packing box includes a part that can be torn along a tear inducing line extending from the flap opposing edge of the top face lid to the front end edge of the top face lid.

Abstract: Problem to be Solved Provided is a packing box that enables to easily release a slit lock in which slits of an insertion piece of an openable lid engage with side flaps connected to openable lid side edge portions of lid side members, even if the interior of a box body of the packing box is tightly filled with a product.

Abstract: Tricyclic benzazepine compounds represented by the following formula (I) and pharmacologically acceptable salts thereof are disclosed. These compounds have antiallergic activity and are useful for treatment and prevention of bronchial asthma, eczema, hives, allergic gastrointestinal troubles, allergic rhinitis, allergic conjunctivitis, etc. wherein R represents a hydrogen atom, substituted C.sub.1-6 alkyl or a protective group and R.sup.1, R.sup.2, R.sup.3, and R.sup.4 represent a hydrogen atom, a hydroxyl group, substituted C.sub.1-4 alkyl, substituted C.sub.2-12 alkenyl, substituted C.sub.1-12 alkoxy, or substituted amino.

Abstract: The present invention relates to an epitaxial wafer including a PN junction, which is improved in terms of light output and can have a good-enough ohmic electrode formed thereon. Epitaxial layers are formed of GaAs.sub.1-x P.sub.x where 0.45 <.times..ltoreq.1). A first P-type layer is formed by a vapor-phase growth process, and a second P-type layer is formed on the first P-type layer by a thermal diffusion process, said second P-type layer having a carrier concentration higher than that of said first P-type layer.

Abstract: Compounds of formulae (II), (III), (IV) and (V) or salts thereof are intermediates for pharmacologically active tricyclic benzazepine and benzothiazepine derivatives, ##STR1## wherein R represents hydrogen, alkyl, phenylalkyl, or a protective group of a triazole ring, R.sup.1 -R.sup.5 represent hydrogen, alkyl, alkenyl, alkoxy, amino, oxim or hydroxyl, and R.sup.41 represents hydrogen, C.sub.1-6 alkyl which may be optionally substituted, or a protective group for a carboxyl group.

Abstract: In an epitaxial wafer of gallium arsenide phosphide, a single crystal substrate is provided thereon with a gallium arsenide phosphide layer with a varying mixed crystal ratio, a gallium arsenide phosphide layer with a constant mixed crystal ratio, and a nitrogen-doped gallium arsenide phosphide layer with a constant mixed crystal ratio. The nitrogen-doped gallium arsenide phosphide layer with a constant mixed crystal ratio has a carrier concentration of 3.times.10.sup.15 cm.sup.-3 or less.

Abstract: The tricyclic benzazepine and benzothiazepine derivatives represented by the formula (I) and pharmacologically acceptable salts thereof are disclosed. ##STR1## wherein Z represents CO, --CR.sup.6 R.sup.7 -- or --S(O).sub.n, R represents hydrogen, alkyl, phenylalkyl, or a protective group of a triazole ring, R.sup.1 -R.sup.5 represent hydrogen, alkyl, alkenyl, alkoxy, amino, oxim or hydroxyl. These compounds have anti-allergic effect and are useful for the treatment and prophylaxis of allergic diseases.